Decreased HDAC2 activity is associated with glucocorticoid resistance, increased oxidative stress, and increased production of pro-inflammatory mediators in alveolar macrophages of patients with COPD [31]. Here, HDAC2 is linked to chronic obstructive pulmonary disease.